Spain · Delayed Price · Currency is EUR Cirsa Enterprises Statistics
Total Valuation
BME:CIRSA has a market cap or net worth of EUR 2.13 billion. The enterprise value is 4.13 billion.
| Market Cap | 2.13B |
| Enterprise Value | 4.13B |
Important Dates
The last earnings date was Thursday, May 21, 2026.
| Earnings Date | May 21, 2026 |
| Ex-Dividend Date | Apr 29, 2026 |
Share Statistics
BME:CIRSA has 167.96 million shares outstanding.
| Current Share Class | 167.96M |
| Shares Outstanding | 167.96M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.00% |
| Owned by Institutions (%) | 2.40% |
| Float | 39.90M |
Valuation Ratios
The trailing PE ratio is 23.93 and the forward PE ratio is 8.09. BME:CIRSA's PEG ratio is 0.28.
| PE Ratio | 23.93 |
| Forward PE | 8.09 |
| PS Ratio | 0.89 |
| PB Ratio | 2.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.76 |
| P/OCF Ratio | 3.18 |
| PEG Ratio | 0.28 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.41, with an EV/FCF ratio of 7.30.
| EV / Earnings | 46.47 |
| EV / Sales | 1.73 |
| EV / EBITDA | 5.41 |
| EV / EBIT | 10.27 |
| EV / FCF | 7.30 |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 2.49.
| Current Ratio | 0.91 |
| Quick Ratio | 0.73 |
| Debt / Equity | 2.49 |
| Debt / EBITDA | 2.92 |
| Debt / FCF | 3.90 |
| Interest Coverage | 1.92 |
Financial Efficiency
Return on equity (ROE) is 25.21% and return on invested capital (ROIC) is 9.25%.
| Return on Equity (ROE) | 25.21% |
| Return on Assets (ROA) | 6.44% |
| Return on Invested Capital (ROIC) | 9.25% |
| Return on Capital Employed (ROCE) | 12.02% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 151,306 |
| Profits Per Employee | 5,636 |
| Employee Count | 15,510 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 30.37 |
Taxes
In the past 12 months, BME:CIRSA has paid 75.20 million in taxes.
| Income Tax | 75.20M |
| Effective Tax Rate | 35.93% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 13.17 |
| 200-Day Moving Average | 14.21 |
| Relative Strength Index (RSI) | 40.69 |
| Average Volume (20 Days) | 141,966 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:CIRSA had revenue of EUR 2.39 billion and earned 88.85 million in profits. Earnings per share was 0.53.
| Revenue | 2.39B |
| Gross Profit | 1.92B |
| Operating Income | 394.89M |
| Pretax Income | 209.31M |
| Net Income | 88.85M |
| EBITDA | 756.17M |
| EBIT | 394.89M |
| Earnings Per Share (EPS) | 0.53 |
Balance Sheet
The company has 314.72 million in cash and 2.21 billion in debt, with a net cash position of -1.89 billion or -11.25 per share.
| Cash & Cash Equivalents | 314.72M |
| Total Debt | 2.21B |
| Net Cash | -1.89B |
| Net Cash Per Share | -11.25 |
| Equity (Book Value) | 887.26M |
| Book Value Per Share | 4.61 |
| Working Capital | -59.73M |
Cash Flow
In the last 12 months, operating cash flow was 668.67 million and capital expenditures -102.75 million, giving a free cash flow of 565.92 million.
| Operating Cash Flow | 668.67M |
| Capital Expenditures | -102.75M |
| Depreciation & Amortization | 369.40M |
| Net Borrowing | -545.54M |
| Free Cash Flow | 565.92M |
| FCF Per Share | 3.37 |
Margins
Gross margin is 80.61%, with operating and profit margins of 16.55% and 3.72%.
| Gross Margin | 80.61% |
| Operating Margin | 16.55% |
| Pretax Margin | 8.77% |
| Profit Margin | 3.72% |
| EBITDA Margin | 31.70% |
| EBIT Margin | 16.55% |
| FCF Margin | 23.72% |
Dividends & Yields
This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 3.55%.
| Dividend Per Share | 0.45 |
| Dividend Yield | 3.55% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 37.40% |
| Buyback Yield | n/a |
| Shareholder Yield | 3.55% |
| Earnings Yield | 4.18% |
| FCF Yield | 26.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BME:CIRSA is 19.70, which is 55.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 19.70 |
| Price Target Difference | 55.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:CIRSA has an Altman Z-Score of 1.42 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.42 |
| Piotroski F-Score | 8 |